Interaction between rosuvastatin and ticagrelor resulting in rhabdomyolysis

被引：0
|
作者：
Sarinic, V. Macolic [1 ]
Sandberg, L. [2 ]
Hartman, J. [2 ]
Caduff-Janosa, P. [2 ]
机构：
[1] Agcy Med Prod & Med Devices, Zagreb, Croatia
[2] Uppsala Monitoring Ctr, WHO Collaborating Ctr Int Drug Monitoring, Uppsala, Sweden
来源：
DRUG SAFETY | 2017年 / 40卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
207
引用
收藏
页码：1014 / 1015
页数：2
相关论文
共 50 条
  • [41] Rhabdomyolysis induced by rosuvastatin combined with entecavir: a case report
    Wen Wang
    Xu Lu
    Chengbo Li
    Wei Teng
    Wei Cui
    BMC Infectious Diseases, 22
  • [42] Fatal Rhabdomyolysis in a COVID-19 Patient on Rosuvastatin
    Anklesaria, Zafia
    Frankman, Jonathan
    Gordin, Jonathan
    Zhan, Jennifer
    Liu, Antonio K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [43] Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin
    Lee, AJ
    Maddix, DS
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (01) : 26 - 31
  • [44] Rhabdomyolysis due to probable interaction between simvastatin and ritonavir
    Cheng, CH
    Miller, C
    Lowe, C
    Pearson, VE
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (08) : 728 - 730
  • [45] RHABDOMYOLYSIS CAUSED BY UNUSUAL INTERACTION BETWEEN SIMVASTATIN AND AZITHROMYCIN
    Alreja, Gaurav
    Inayatullah, Sadiq
    Goel, Saurabh
    Braden, Gregory
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A20 - A20
  • [46] Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine
    Yochai Birnbaum
    Gilad D. Birnbaum
    Itamar Birnbaum
    Sven Nylander
    Yumei Ye
    Cardiovascular Drugs and Therapy, 2016, 30 : 539 - 550
  • [47] Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine
    Birnbaum, Yochai
    Birnbaum, Gilad D.
    Birnbaum, Itamar
    Nylander, Sven
    Ye, Yumei
    CARDIOVASCULAR DRUGS AND THERAPY, 2016, 30 (06) : 539 - 550
  • [48] Amiodarone/rosuvastatin/sacubitril/valsartan interactionIncrease in rosuvastatin plasma concentrations and subsequent rhabdomyolysis: case report
    Reactions Weekly, 2019, 1762 (1) : 33 - 33
  • [49] PHARMACOKINETIC INTERACTION BETWEEN ROSUVASTATIN AND FENOFIBRATE IN HEALTHY VOLUNTEERS.
    Yi, S.
    Kim, M.
    Han, S.
    Park, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S62 - S62
  • [50] Acute renal failure due to rhabdomyolysis in relation to abiraterone and rosuvastatin
    Cintra, Melissa
    Pedraza Cezon, Luis A.
    Martin Navarro, Juan A.
    Torres Aguilera, Esther
    Albalate Ramon, Marta
    Alcazar Arroyo, Roberto
    Procaccini, Fabio
    Puerta Carretero, Marta
    Ortega Diaz, Mayra
    Medina Zahonero, Laura
    Jaldo Rodriguez, Maria T.
    de Sequera, Patricia
    NEFROLOGIA, 2023, 43 (03): : 374 - 376
12345